Santen Pharmaceutical Co Stock Analysis

Santen Pink Sheet Analysis Notes

About 54.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.39. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Santen Pharmaceutical last dividend was issued on the 30th of March 2023. The entity had 5:1 split on the 27th of March 2015. Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan. Santen Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 4315 people.The quote for Santen Pharmaceutical Co is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Santen Pharmaceutical Co contact the company at 81 6 7664 8621 or learn more at https://www.santen.com.

Santen Pharmaceutical Investment Alerts

Santen Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.95 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Santen Pharmaceutical's market, we take the total number of its shares issued and multiply it by Santen Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Santen Profitablity

The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.

Technical Drivers

As of the 13th of December 2024, Santen Pharmaceutical has the Variance of 5.28, risk adjusted performance of (0.01), and Coefficient Of Variation of (4,009). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Santen Pharmaceutical, as well as the relationship between them. Please validate Santen Pharmaceutical market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Santen Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 10.53 per share. Given that Santen Pharmaceutical has information ratio of (0.07), we advise you to double-check Santen Pharmaceutical Co's current market performance to make sure the company can sustain itself at a future point.

Santen Pharmaceutical Price Movement Analysis

Santen Pharmaceutical Predictive Daily Indicators

Santen Pharmaceutical Forecast Models

Santen Pharmaceutical's time-series forecasting models are one of many Santen Pharmaceutical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Santen Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Santen Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Santen shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Santen Pharmaceutical. By using and applying Santen Pink Sheet analysis, traders can create a robust methodology for identifying Santen entry and exit points for their positions.

When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.